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This study examined actin regulation of ﬁbroblast matrix genes in dedifferentiated chondrocytes.
We demonstrated that dedifferentiated chondrocytes exhibit increased actin polymerization,
nuclear localization of myocardin related transcription factor (MRTF), increased type I collagen
(col1) and tenascin C (Tnc) gene expression, and decreased Sox9 gene expression. Induction of actin
depolymerization by latrunculin treatment or cell rounding, reduced MRTF nuclear localization,
repressed col1 and Tnc expression, and increased Sox9 gene expression in dedifferentiated chondro-
cytes. Treatment of passaged chondrocytes with MRTF inhibitor repressed col1 and Tnc expression,
but did not affect Sox9 expression. Our results show that actin polymerization regulates ﬁbroblast
matrix gene expression through MRTF in passaged chondrocytes.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Autologous cell-based articular cartilage repair requires access
to a source of sufﬁcient cells capable of producing articular carti-
lage matrix. Expansion of chondrocytes in two-dimensional (2D)
polystyrene cell culture is capable of providing a large number of
cells, however, this results in dedifferentiation. Dedifferentiation
is characterized by reduced expression of articular cartilage matrix
molecules such as aggrecan (acan) and type II collagen (col2) [1–3]
as well as increased expression of ﬁbroblastic matrix molecules
such as type I collagen (col1) and tenascin C (tnc) [3,4]. This is
characteristic of ﬁbrocartilage-type matrix which is biomechani-
cally inferior and incapable of withstanding the loading associated
with daily use (fails after 7 years) [5].
In addition, passaged cells are large, spread, and have actin
organized into stress ﬁbers. This is in contrast to small, round pri-
mary chondrocytes with cortical distribution of actin. Cell shape
and actin stress ﬁber organization are important in the regulationof the dedifferentiated cell phenotype [1,3,6]. Exposure of passaged
chondrocytes to actin depolymerization agents to prevent cell
spreading or induce cell rounding not only leads to reexpression
of cartilage matrix genes [7], but also reduced col1 expression [8].
Sox9 is known as the master transcriptional factor regulating
expression of chondrogenic matrix molecules [9], such as col2
and acan. For chondrocytes, actin depolymerization has been
shown to regulate sox9 activity through protein kinase A (PKA) sig-
naling [10]. While the actin based pathways that enhance cartilage
matrix genes has been elucidated, the pathway(s) regulating ﬁbro-
blast matrix genes, such as col1 and tnc in dedifferentiated cells
remains unclear. In other cell types, actin has been shown to regu-
late col1 and tnc gene expression through the myocardin related
transcription factor (MRTF) [11,12]. MRTF is a co-activator of
serum response factor (SRF). The MRTF/SRF complex binds to the
CArG regulatory sequence (CC(A/T)6GG) in the promoter regions
of target genes. In addition, MRTF also contains actin binding
motifs and has strong afﬁnity for the monomeric, globular (g-)
actin [13]. Depolymerization of ﬁlamentous (f-) actin into g-actin
results in MRTF binding to g-actin and localizing MRTF in the cyto-
plasm resulting in a decrease in MRTF regulated gene expression.
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sion in dedifferentiated chondrocytes is important if passaged
chondrocytes are to be used for cartilage repair. To our knowledge,
no studies have identiﬁed MRTF regulation of gene expression in
passaged chondrocytes. The hypothesis being examined in this
study is that chondrocyte passaging on 2D polystyrene promotes cell
spreading and actin polymerization resulting in an increased
proportion of MRTF in the nucleus and enhanced expression of
ﬁbroblast matrix genes, col1 and tnc. Preventing or limiting nuclear
translocation of MRTF either through MRTF chemical inhibition or
through actin depolymerization will repress ﬁbroblast matrix gene
expression.2. Materials and methods
2.1. Cell culture
Bovine articular chondrocytes were isolated and passaged twice
(P2) as described previously with slight modiﬁcations [14].
Approximately 1.5  103 cells/cm2 were initially seeded and main-
tained in complete media (Ham’s F12 supplemented with 5%FBS
and anti-mycotic/-biotic). After approximately 13–15 days in
culture when cells reached 80–90% conﬂuency, the cells were tryp-
sinized and were considered as passaged once (P1) chondrocytes.
P1 chondrocytes were then re-seeded at 1.5  103 cells/cm2 and
cultured for another 7–9 days until 80–90% conﬂuency was
reached. These cells were trypsinized and then seeded at 3  104
cells/cm2 for the different experiments. To investigate f-actin and
MRTF localization, cells were plated on glass slides in complete
media. For gene expression studies, cells were seeded on polysty-
rene. After 2 days, cells were washed in PBS prior to processing.
To investigate the effects of cell rounding, cells were cultured in
suspension on agarose. 2% agarose was prepared in Ham’s F12
and autoclave sterilized. Molten agarose was overlaid onto culture
vessels to a thickness of 2 mm.
2.2. Treatment of P2 chondrocytes with latrunculin B or CCG1423
P2 chondrocytes were seeded either on glass slides (for immu-
nocytochemistry), on polystyrene 6 well plates (for RT-PCR), or on
T175 polystyrene ﬂasks (protein analysis). For latrunculin B treat-
ment, P2 chondrocytes were seeded in complete media. After
2 days, media was replenished either with complete media
containing 1 lm latrunculin B or an equivalent volume of DMSO
carrier control. For CCG1423 treatment, P2 chondrocytes were
seeded in serum reduced media (Ham’s F12 supplemented with
0.5%FBS and anti-mycotic/-biotic). After 2 days, media was replen-
ished with fresh serum reduced media containing 10 lM CCG1423
or an equivalent volume of DMSO carrier control. Following 24 h of
treatment, cells were harvested for analysis.
2.3. Cell area and circularity
Cells were washed with PBS and then incubated with calcein
AM (Santa Cruz) diluted in PBS (1:5000) for 10 min at room tem-
perature. Images were acquired with a Leica ﬂuorescent DM IL
microscope and processed based on a previously published proto-
col [15]. Using Image J, images were converted to 8-bit and thresh-
old adjusted to minimize background noise. The ‘analyze particles’
function was used to determine cell area and circularity. Circularity
was deﬁned as C = 4pi(A/P2), where P is cell perimeter and A is cell
area. A circularity value of 1.0 indicates perfect circular morphol-
ogy whereas a value of 0.0 would indicate an elongated polygon.
A total number of at least 100 cells for each condition were
evaluated from at least 3 different calves.2.4. Immunocytochemistry
Cells on glass slides were ﬁxed in 4% paraformaldehyde at room
temperature for 10 min. Cells were permeabilized in 0.1% triton/
PBS for 30 min and then incubated with rabbit polyclonal anti-
MRTF-a antibody (Abcam; Cambridge, MA, USA; dilution of 1:200
in 0.1% triton/PBS). After overnight incubation, slides were washed
and then incubated in anti-rabbit IgG conjugated Alexa488 (dilu-
tion 1:250 in 0.1% triton/PBS) followed by an hour incubation in
Alexa-598 phalloidin conjugate as a counterstain. Images were
obtained at a standard location in the cells using a Nikon C1si laser
scanning confocal microscope equipped with NIS Elements
software.
Immunocytochemistry on suspension cultures was performed
in a similar manner, however, cells were pelleted at 600 g for
5 min, resuspended in 4% paraformaldehyde at a density of approx-
imately 5  103 cells/0.1 mL, placed on a glass slide and air dried at
37 C for 30 min prior to primary antibody incubation.
2.5. Protein extraction
Adherent cells were scraped from 2D cultures and then pelleted
by centrifugation at 800g for 3 min. For suspension cultures, cells
were pelleted ﬁrst in media, washed in PBS and then re-pelleted.
Pellets were resuspended in RIPA buffer (50 mM Tris HCl,
150 mMNaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) with
complete mini protease inhibitor (Roche; Manheim, Germany).
Debris was removed by centrifugation at 14,000g at 4 C for
30 min and total protein was quantiﬁed using bicinchoninic acid
protein assay (Thermo Scientiﬁc; Waltham, MA, USA).
Nuclear and cytoplasmic protein was extracted from cells using
a NE-PER Nuclear and Cytoplasmic Extraction kit (Thermo Scien-
tiﬁc). Cells were ﬁrst scraped off ﬂasks, pelleted, and then nuclear
and cytoplasmic fractions were separated as per manufacturer’s
instructions and then quantiﬁed.
2.6. Analysis of g-/f-actin protein levels
G- and f-actin portions were separated by triton solubility as
previously described with slight modiﬁcations [16]. Following
treatment, cells were washed in PBS, then scraped off polystyrene
ﬂasks, suspended in PBS and pelleted. Pellets were resuspended in
250 lL of extraction buffer (0.1% triton X-100 in PBS and complete
protease inhibitor) and incubated for 5 min under slight agitation.
The samples were then centrifuged at 15,000g at 4 C for 5 min.
The soluble portions (supernatant; predominantly globular actin)
was collected. The triton-insoluble (pellet; predominantly ﬁlamen-
tous actin) was resuspended in 250 lL of RIPA buffer and agitated
for 30 min.
2.7. SDS–PAGE and Western blotting
Proteins were prepared for SDS–PAGE by heating in Laemmli
buffer for 10 min at 98 C. To evaluate total protein extracts,
30 lg of protein were separated in a 12% SDS–PAGE gel. For actin
assays, equal volumes of the soluble and insoluble protein fractions
were loaded. Following adequate separation, proteins were semi-
dry transferred onto polyvinylidene ﬂuoride (PVDF) membranes
using an iBLOT transfer system (Life Technologies). Membranes
were then incubated in blocking buffer (5% skim milk) for 30 min
and then incubated in primary antibody using the dilutions listed
in Supplementary Table 1. Following an overnight incubation,
membranes were washed in 0.005% Tween/PBS and then incubated
at room temperature for 1 h in HRP conjugated secondary antibody
(1:20,000; Abcam). Chemiluminescent signals were developed
using Pierce ECL Western Blot Substrate (Thermo Scientiﬁc) in a
J. Parreno et al. / FEBS Letters 588 (2014) 3677–3684 3679dark room. Protein bands were semi-quantiﬁed through densitom-
etry using Image J software.
2.8. RNA isolation and reverse transcription-polymerase chain reaction
(RT-PCR)
Total RNA was isolated from cells using TRIzol reagent accord-
ing to manufacturer’s instructions. RNA was reverse transcribed
with SuperScript III Reverse Transcriptase (Life Technologies, Carls-
bad, CA, USA) and ampliﬁed utilizing a Mastercycler Thermocycler
(Eppendorf, AG, Hamburg, Germany). Relative real-time PCR was
performed using Fast SYBR Green I Master Mix (Applied
Biosystems, Foster City, CA, USA) with primers designed for the
genes listed in Supplementary Table 2. Thermal cycling and
ﬂuorescent detection was performed using a LightCycler 96
Real-Time PCR System (Roche).
2.9. Statistical analysis
Each experiment was performed with 3–6 replicates and
repeated 3–4 times in independent experiments. T-tests were
utilized to analyze differences between two groups. Univariate
analysis of variance (ANOVA) was performed when an analysis0
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Fig. 1. Expansion of chondrocyte cell number in monolayer culture results in a dediffere
for 2 days. (A) Photomicrographs of P0 and P2 chondrocytes revealed that passa
circularity ± standard error of mean. Scale bar = 100 lm. (B) Confocal images showing di
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3. Results
3.1. P2 chondrocytes have reduced g-/f-actin and increased nuclear
accumulation of MRTF
P2 chondrocytes were signiﬁcantly larger and more spread as
compared to P0 chondrocytes (Fig. 1A; S1 and S2). P0 chondrocytes
organized actin cortically whereas in P2 chondrocytes actin was
organized into stress ﬁbers (Fig. 1B). P0 chondrocytes had a signif-
icantly higher g-/f-actin as compared to P2 chondrocytes (Fig. 1C).
Total MRTF levels were signiﬁcantly higher in P2 chondrocytes
(Fig. 1D) and there were a greater proportion of P2 chondrocytes with
MRTF located in the nucleus as compared to P0 chondrocytes (91% in
P2 versus 67% in P0; P < 0.05; Fig. 1B and E).
3.2. CCG1423 treatment resulted in cytoplasmic localization of MRTF,
and decreased col1 and tnc expression
Regulation of gene expression by MRTF was investigated by
exposing P2 chondrocytes to the small molecule inhibitor,g gf f
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drocytes. g = globular actin; f = ﬁlamentous actin (C) and total MRTF in P0 and P2
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[17] through binding of the N-terminal basic domain of MRTF
[18]. CCG1423 experiments were conducted in serum-free medium
to reduce serum activation of gene expression [19]. P2 chondro-
cytes treated with CCG1423 (CCG1423+) maintained a ﬂattened,
spread morphology (Fig. 2A) with actin organized into stress ﬁbers
(Fig. 2B), although the cells exposed to CCG1423 were signiﬁcantly
smaller (Figs. 2A and S3) and rounder compared to untreated P2
chondrocytes (Fig. S4). There was a trend toward increased g-/f-
actin, however, this was not signiﬁcantly different between treated
and untreated (CCG1423) cells (Fig. 2C). MRTF localization was
signiﬁcantly altered as there were a signiﬁcantly lower proportion
of cells that had nuclear MRTF (Fig. 2B and D).
The mRNA levels for col1 and tnc were elevated in P2 chondro-
cytes (Fig. 2E) 741- and 2.4-fold, respectively. CCG1423 treatment
resulted in decreased col1 and tnc mRNA levels 3.4- and 1.4-fold,
respectively. Nevertheless, these were still elevated over P0 chon-
drocyte levels. As compared to P0 chondrocytes, acan and col2
remained low in control as well as CCG1423 treated P2 chondro-
cytes (Fig. S5). While there was a trend toward increased sox9 fol-
lowing CCG1423 exposure, this was not statistically signiﬁcant.A BCCG1423-
CCG1423+
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Fig. 2. Exposure of P2 chondrocytes to MRTF inhibitor, CCG1423, repressed col1 and tnc
revealed that cells were still spread following treatment. Scale bar = 100 lm. (B) Con
(CCG1423+) treatment, however, nuclear MRTF appeared reduced. Scale bar = 50 lm;
difference in actin polymerization status and (D) bar graph demonstrating proportion o
nucleus and cytoplasm (gray), or predominantly cytoplasmic (white). (E) Gene expressio
effect on sox9 mRNA levels. (F) Western blot indicating CCG1423 treatment reduced type
compared to P2 control cells.Since col1 was substantially modulated in P2 chondrocytes fol-
lowing CCG1423 treatment, the effect of CCG1423 on col1 protein
was investigated. The antibody utilized in this study recognizes
both the a1 and a2 chains of col1. Western blots using this anti-
body revealed higher amounts of a1 chain as compared to the a2
chain in P2 chondrocytes cultured in complete media (data not
shown). However, in serum-reduced conditions the band intensity
of a2 was greater than a1 (Fig. 2F) suggesting serum-dependent
differential regulation of the chains. Nevertheless, CCG1423 treat-
ment repressed both a1 and a2 chains of type I collagen in serum-
reduced conditions.
3.3. Latrunculin B treatment of P2 chondrocytes resulted in cell
rounding, increased g-/f-actin, cytoplasmic localization of MRTF,
reduced expression of col1 and tnc, and enhanced sox9 mRNA levels
To investigate the effect of actin depolymerization on P2 chon-
drocytes, cells were exposed to latrunculin. Latrunculin promotes
actin depolymerization by binding in a 1:1 ratio with g-actin
[20]. Unlike other actin depolymerization promoting agents, such
as cytochalasin D, latrunculin does not interfere with theC
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J. Parreno et al. / FEBS Letters 588 (2014) 3677–3684 3681interaction between MRTF and actin [21] and was therefore uti-
lized in this study. Exposure of P2 chondrocytes to latrunculin
resulted in signiﬁcantly smaller cells (Figs. 3A and S6) that were
rounder (Fig. S7) and had diminished actin stress ﬁber organization
(Fig. 3B). Latrunculin treated P2 chondrocyte actin organization did
not fully resemble P0 chondrocytes as cortical actin distribution
was not established. However, compared to untreated cells the
g-/f-actin ratio was signiﬁcantly enhanced by latrunculin treat-
ment (Fig. 3C).
Latrunculin treatment resulted in a smaller proportion of P2
chondrocytes that had nuclear MRTF as compared to control cells
(9% in latrunculin+ versus 80% in latrunculin; P < 0.05; Fig. 2B
and D). This was conﬁrmed by Western blot analysis, which
showed a reduced amount of nuclear MRTF in latrunculin treated
cells as compared to untreated control cells (Fig. 3E).
Exposure of P2 cells to latrunculin repressed col1 and tnc mRNA
levels 2.0- and 1.5-fold respectively (Fig. 3F). Despite this reduc-
tion, col1 and tnc mRNA levels in P0 chondrocytes were still signif-
icantly lower than latrunculin treated P2 chondrocytes.
Latrunculin treatment did not lead to recovery of col2 or acan
expression (Fig. S8). However, it led to a 5.1-fold recovery inD
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Fig. 3. Exposure of P2 chondrocytes to latrunculin (latrunculin+) decreases features of
exposure to latrunculin reduced cell size and induced cell rounding. Scale bar = 100 lm.
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levels. aP < 0.05 as compared to P0 chondrocytes; bP < 0.05 as compared to P2 control cesox9 mRNA expression which was still signiﬁcantly lower than
P0 chondrocyte levels (Fig. 3F).
3.4. Cell rounding through culture of P2 chondrocytes in suspension
resulted in increased g-/f-actin, cytoplasmic localization of MRTF, and
reduced expression of col1 and tnc
Cells in suspension culture were signiﬁcantly smaller (Figs. 4A
and S9) and rounder (Fig. S10) as compared to cells in monolayer.
Cells also had reduced f-actin with no apparent stress ﬁbers
(Fig. 4B). Furthermore, cells in suspension had signiﬁcantly ele-
vated g-/f-actin ratio (Fig. 4C) and a smaller proportion of cells with
nuclear MRTF as compared to cells in monolayer culture (Fig. 4D).
Suspension culture signiﬁcantly repressed gene expression lev-
els for col1 and tnc 9.8-fold and 1.6-fold, respectively. Despite the
reduction in gene expression, the levels in P0 chondrocytes were
still signiﬁcantly lower as compared to those in P2 chondrocytes
in suspension. Col2 and acan were not recovered by culture in sus-
pension (Fig. S10). While sox9 mRNA levels were increased 5.9-
fold, sox9 levels for cells in suspension were still signiﬁcantly
lower than P0 chondrocytes.0
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Monolayer expansion of chondrocytes for cell-based articular
cartilage repair is problematic as it results in dedifferentiated
chondrocytes that produce ﬁbrocartilage-type matrix. This study
demonstrated that the expression of ﬁbroblast matrix genes, col1
and tnc, is regulated by actin polymerization through MRTF in
dedifferentiated chondrocytes. These cells have increased actin
polymerization and a higher proportion of MRTF nuclear localiza-
tion as compared to primary chondrocytes. Additionally, inducing
actin depolymerization in dedifferentiated chondrocytes resulted
in cytoplasmic localization of MRTF and reduced col1 and tnc gene
expression.
Dedifferentiated cells show changes in cell shape and actin
organization, both of which have been shown to be regulators of
chondrogenic gene expression [6,22]. We found that ﬁbroblastic
matrix expression of col1 (similar to previous studies [8,22]) and
also tnc correlated with both shape and actin organization. To fur-
ther elucidate how shape or actin organization regulates ﬁbroblas-
tic matrix gene expression in chondrocytes, we investigated the
actin polymerization status of cells as it has been shown to be
a key regulator of gene expression for other cell types [21,23].
Firstly, we found that cell shape and actin polymerization wereinterrelated (Fig. 5); inducing cell rounding led to actin depolymer-
ization and vice versa. Secondly, we observed a correlation
between actin organization and polymerization status; P2 chon-
drocytes displaying stress ﬁbers had a greater proportion of poly-
merized actin as compared to P0 chondrocytes where actin was
cortically distributed. Thus the regulation of gene expression by
shape or actin organization can occur through modulation of actin
polymerization status. Increasing evidence has shown that the
J. Parreno et al. / FEBS Letters 588 (2014) 3677–3684 3683actin polymerization state regulates gene expression through the
transport of actin binding proteins into and out of the nucleus
[21,23]. MRTF in particular, which is one of the best characterized
g-actin binding proteins, has the ability to regulate col1 [11] and
tnc [12] gene expression in other cell types.
Our results revealed that col1 and tnc gene expression in P2
chondrocytes was dependent in part on MRTF. As shown in other
cell types, nuclear localization of MRTF allows it to associate and
act as a transcriptional co-activator to SRF on promoter regions
[21], and therefore enhancing col1 and tnc gene expression
(Fig. 5). Interestingly, we have found that culture of P2 chondro-
cytes in 3D micromass cultures results in actin depolymerization
and repressed col1 and tnc gene expression (data not shown)
which may be the result of decreased SRF activity that occurs in
micromass culture of cells [24]. Nevertheless, tnc is also regulated
by SRF independent mechanisms [12], therefore the exact down-
stream mechanism(s) by which MRTF regulates col1 and tnc
expression in chondrocytes requires further investigation. Further-
more although we conducted CCG1423 experiments in serum-
reduced conditions, CCG1423 treatment of cells in complete media
also led to signiﬁcantly reduced expression of col1 and tnc mRNA
levels (data not shown). The magnitude of repression for tnc mRNA
levels by CCG1423 treatment in complete media (1.5-fold) was
similar to that in serum-reduced conditions. However, the effect
on col1 gene expression was affected by serum as the magnitude
of repression in complete media (1.4-fold) by CCG1423 was less
than that in serum reduced conditions (3.5-fold). Interestingly
serum can enhance SRF-regulated genes independent of MRTF
[19] and therefore an elucidation of other pathways regulating
SRF in chondrocytes is required. Additionally, further examination
to determine what other genes are regulated by MRTF and/or SRF
in chondrocytes is also critical. Of note, MRTF has been shown to
regulate molecules associated with actin polymerization [19].
Moreover, SRF has been considered as the ‘master transcriptional
regulator of the cytoskeleton’ with over 200 SRF target genes asso-
ciated with actin [25]. Therefore a feedback loop whereby MRTF
and/or SRF also regulate actin polymerization could exist (Fig. 5).
While exposure of cells to CCG1423 for 24 h appeared to slightly
increase g-/f-actin in the present study, these increases were not
statistically signiﬁcant. It remains to be determined if longer term
MRTF inhibition through prolonged CCG1423 treatment or MRTF
knockdown can induce actin depolymerization. This is of interest
as MRTF could potentially have greater, yet indirect, effects on
chondrogenic phenotype by regulating actin polymerization status.
The ﬁnding that actin depolymerization, but not MRTF inhibi-
tion, affected sox9 gene expression suggests that actin depolymer-
ization directly regulates expression of sox9 through a pathway
independent of MRTF (Fig. 5). While we did not investigate the pre-
cise signaling mechanisms regulating sox9 by actin depolymeriza-
tion, actin depolymerization has been shown to enhance both sox9
transcription and activity through a PKA dependent mechanism
[10]. Thus it appears likely that actin depolymerization utilizes
both MRTF and PKA signaling to regulate ﬁbroblastic and chondro-
genic matrix, respectively.
Despite the favorable changes induced through actin depoly-
merization, these were insufﬁcient and further cellular modulation
is required for full redifferentiation of passaged chondrocytes. This
is based on our ﬁndings that actin depolymerization in P2 chondro-
cytes did not completely reduce col1 and tnc gene expression to
levels seen in P0 chondrocytes. As well, unlike previous studies
[8,26], col2 and acan mRNA levels were not increased by actin
depolymerization. One explanation for the lack of full redifferenti-
ation is that the P2 chondrocytes utilized in this study may be
more dedifferentiated. In comparison to other studies [7,27], we
seeded cells at a lower density for passaging and also cultured
them for a longer period of time. Therefore because the recoveryof chondrogenic matrix gene expression is dependent on the dedif-
ferentiation state of cells [28], full redifferentiation may require
more time and another stimulus. More time appears to be required
as Sox9, a potent activator of chondrogenic expression, was upreg-
ulated with actin depolymerization in our study and it is possible
this chondrogenic gene expression was initiated but not fully man-
ifested. Additionally, another stimulus may be essential as we were
unable to induce cortical actin distribution in the cells which
appear to be critical for full redifferentiation [29]. Stimuli used to
obtain cortical actin in cells are three-dimensional (3D) culture
[30] as well as insulin [31]. Interestingly, 4-week cultures of pas-
saged chondrocytes in 3D maintained in serum-free media supple-
mented with insulin lead to redifferentiation of passaged
chondrocytes and formation of hyaline cartilage [32].
In conclusion this study shows that actin polymerization status
regulates passaged chondrocyte expression of ﬁbroblastic matrix
genes through MRTF. As ﬁbrocartilage matrix formation is a conse-
quence of the in vivo healing response to cartilage damage [33] as
well as is characteristic of in vitro passaged chondrocytes used for
autologous cell-based therapies [34], modulating MRTF would be a
way to prevent or suppress ﬁbrocartilage formation. Further studies
are required to determine the pathways involved in full redifferen-
tiation to generate chondrocytes for use in articular cartilage repair.
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